Endeavor BioMedicines is a startup based in the United States.
Based in the United States, Endeavor BioMedicines is a startup.
Endeavor BioMedicines is a clinical-stage biotechnology company developing therapeutics targeting the Hedgehog signaling pathway, with a lead candidate, taladegib (ENV-101), in clinical trials for treating fibrotic lung diseases such as idiopathic pulmonary fibrosis.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.